TY - CHAP M1 - Book, Section TI - Anesthetic Implications of Poor Cardiac Function A1 - Sharma, Sonal A1 - Durieux, Marcel E. A2 - Johnson, Ken B. PY - 2015 T2 - Clinical Pharmacology for Anesthesiology AB - Heart failure is increasingly being recognized as a growing health problem worldwide. It is estimated that the lifetime risk of developing heart failure is approximately 20% for patients older than 40 years.1 Clinical anesthesiologists can therefore expect to see cases involving patients suffering from heart failure with increasing frequency. Symptomatic heart failure is associated with high risk of morbidity and mortality as a result of perioperative ischemia/infarction, dysrhythmias, worsening heart failure, postoperative cognitive dysfunction, and stroke.2,3 Asymptomatic left ventricular dysfunction, which is considered a precursor of symptomatic heart failure and is assumed to have similar prevalence as symptomatic heart failure, is also associated with high perioperative mortality.4 Since most anesthetics interfere with cardiovascular performance, either by direct myocardial depression or by depression of sympathetic activity, on which these patients rely, an appropriate anesthetic technique must be selected to minimize hemodynamic changes and maintain a near-normal physiologic status. This chapter discusses the aspects of dose reduction, titration of drugs, and the pharmacodynamic effects of each class of anesthetic drugs. As an example, the chapter provides a practical guide to the selection and use of general anesthetic agents in patients with poor cardiac function undergoing colectomy and discusses the pharmacologic management of acute cardiac deterioration. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/04/16 UR - accessanesthesiology.mhmedical.com/content.aspx?aid=1103964564 ER -